Document
IPR2018-00685, No. 1002-2 Exhibit - Declaration of Michael J Thirman, MD (P.T.A.B. Feb. 23, 2018)
Cite Document
IPR2018-00685, No. 1002-2 Exhibit - Declaration of Michael J Thirman, MD (P.T.A.B. Feb. 23, 2018)
+ More Snippets
Document
IPR2018-00685, No. 1006-6 Exhibit - Celgene Press Release on June 19, 2006 (P.T.A.B. Feb. 23, 2018)
Cite Document
IPR2018-00685, No. 1006-6 Exhibit - Celgene Press Release on June 19, 2006 (P.T.A.B. Feb. 23, 2018)
+ More Snippets
Document
IPR2018-00685, No. 1017-17 Exhibit - Mark J Cameron and David J Kelvin, Cytokines, Chemokines and Their Receptors (P.T.A.B. Feb. 23, 2018)
Cite Document
IPR2018-00685, No. 1017-17 Exhibit - Mark J Cameron and David J Kelvin, Cytokines, Chemokines and Their Receptors (P.T.A.B. Feb. 23, 2018)
+ More Snippets
Document
IPR2018-00685, No. 1007 Exhibit - US Application No 12621,502, Response to Office Action dated Dec 18, 2013 (P.T.A.B. Feb. 23, 2018)
Cite Document
IPR2018-00685, No. 1007 Exhibit - US Application No 12621,502, Response to Office Action dated Dec 18, 2013 (P.T.A.B. Feb. 23, 2018)
+ More Snippets
Document
IPR2018-00685, No. 1005 Exhibit - Querfeld, C et al, Preliminary Results of a Phase II Study of CC 5013 Lenalidomide, Revlimid¿¿ in Patients with Cutaneous T Cell Lymphoma (P.T.A.B. Feb. 23, 2...
Cite Document
IPR2018-00685, No. 1005 Exhibit - Querfeld, C et al, Preliminary Results of a Phase II Study of CC 5013 Lenalidomide, Revlimid¿¿ in Patients with Cutaneous T Cell Lymphoma (P.T.A.B. Feb. 23, 2018)
+ More Snippets
Document
IPR2018-00685, No. 1002 Exhibit - Declaration of Michael J Thirman, MD (P.T.A.B. Feb. 23, 2018)
Cite Document
IPR2018-00685, No. 1002 Exhibit - Declaration of Michael J Thirman, MD (P.T.A.B. Feb. 23, 2018)
+ More Snippets
Document
IPR2018-00685, No. 1016 Exhibit - Goy, A, New Directions in the Treatment of Mantle Cell Lymphoma An Overview (P.T.A.B. Feb. 23, 2018)
Cite Document
IPR2018-00685, No. 1016 Exhibit - Goy, A, New Directions in the Treatment of Mantle Cell Lymphoma An Overview (P.T.A.B. Feb. 23, 2018)
+ More Snippets
Document
IPR2018-00685, No. 1012 Exhibit - Wiernik, H et al, Preliminary Results from a Phase II Study of Lenalidomide Monotherapy in Relapsed andor refractory Aggressive Non Hodgkins Lymphoma ab...
Cite Document
IPR2018-00685, No. 1012 Exhibit - Wiernik, H et al, Preliminary Results from a Phase II Study of Lenalidomide Monotherapy in Relapsed andor refractory Aggressive Non Hodgkins Lymphoma abstract (P.T.A.
+ More Snippets
Document
REVLIMID, 021880, Letter (Orange Book Sep. 24, 2020)
Cite Document
REVLIMID, 021880, Letter (Orange Book Sep. 24, 2020)
+ More Snippets
Document
REVLIMID, 021880, Letter (Orange Book Oct. 30, 2019)
Cite Document
REVLIMID, 021880, Letter (Orange Book Oct. 30, 2019)
+ More Snippets
Document
REVLIMID, 021880, Label (Orange Book Oct. 30, 2019)
Cite Document
REVLIMID, 021880, Label (Orange Book Oct. 30, 2019)
+ More Snippets
Document
REVLIMID, 021880, Letter (Orange Book May. 28, 2019)
Cite Document
REVLIMID, 021880, Letter (Orange Book May. 28, 2019)
+ More Snippets
Document
REVLIMID, 021880, Label (Orange Book May. 28, 2019)
Cite Document
REVLIMID, 021880, Label (Orange Book May. 28, 2019)
+ More Snippets
Document
REVLIMID, 021880, Label (Orange Book Jan. 22, 2019)
Cite Document
REVLIMID, 021880, Label (Orange Book Jan. 22, 2019)
+ More Snippets
Document
REVLIMID, 021880, Letter (Orange Book Jan. 22, 2019)
Cite Document
REVLIMID, 021880, Letter (Orange Book Jan. 22, 2019)
+ More Snippets